NASDAQ
No price data available for this timeframe.
Stoke Therapeutics, Inc. (STOK) has a price/sales ratio of 10.19x as of Friday, May 22, 2026. This represents a 43.06% decrease compared to its 12-month average of 17.90x. The price-to-sales ratio evaluates a company's stock price relative to its revenue, useful for valuing companies with little or no earnings.